Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Liposomal daunorubicin 2mg/mL injection emulsion 25mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
|
Daunorubicin citrate liposomal 2mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
|
Product containing daunorubicin liposome |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
|
Daunorubicin citrate liposome (substance) |
Is a |
False |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
|
Daunorubicin citrate liposome (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
|
Product containing only daunorubicin liposome (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
1 |
Product containing only daunorubicin liposome in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
1 |
Daunorubicin hydrochloride liposome (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
|
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
2 |
Product containing only cytarabine liposome and daunorubicin liposome (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
2 |
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Some |
2 |